Gilead Sciences Stock
Coronavirus-Driven Market Puts Emphasis on Pharma Stocks As you'd expect during a pandemic, those who make medicine are among the best situated to eke out a profit, even as most other stocks tumble. Considering that gold and bonds and other traditional safe-haven investments are falling at the moment,…
Market Correction Presents Opportunity for Investors The stock market is in free fall right now. Between the novel coronavirus (COVID-19) causing global panic and the recent plunge in oil prices due to tensions between Saudi Arabia—and to a lesser extent the Organization of the Petroleum Producing Countries (OPEC)—and…
GILD Stock: Bullish Developments Wow, Gilead Sciences, Inc. (NASDAQ:GILD) stock has just taken a serious turn, and the timing could not have been any better. In a June 14 publication titled "Gilead Stock Needs to Conquer These Hurdles," I focused on GILD stock and outlined the developments that I would…
GILD Stock: Potentially Bullish? It has been quite a disappointing year for Gilead Sciences, Inc. (NASDAQ:GILD) stock, as its performance year-to-date is -25%. This performance is not surprising, and I have outlined numerous times in my previous reports why I am bearish on Gilead stock . My bearish views are…
GILD Stock: Value Trap? Gilead Sciences, Inc. (NASDAQ:GILD) stock is a heavyweight in the biotech space; the company bolsters a $105.0-billion market cap and ranks high among its competitors like GlaxoSmithKline plc (NYSE:GSK) and Pfizer Inc. (NYSE:PFE). The biotech space has been known to make and break many…